GlycanAge
PrivateLast Round
Series A
Dec 18, 2025
Total Funding Raised
$52.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GlycanAge operates in Healthcare & Life Sciences and is based in Newcastle upon Tyne. Its latest recorded funding round was a Series A round in December 2025.
GlycanAge is a biotech company that provides a biological age test designed to discover, measure, and optimize longevity by analyzing glycan biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands, Healthcare Analytics
Business Model
B2C
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlycanAge Comparables
Compare GlycanAge with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NOVOS | 84% | |
| InsideTracker | 79% | |
| Generation Lab | 78% |
For institutional investors. Book with your work email.
GlycanAge Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 18, 2025 | ||||
| Seed | Feb 19, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GlycanAge Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LaunchHub Ventures | Series A |
| Lightfield Equity | Series A |
| South Central Ventures | Series A |
| BrightCap Ventures | Series A |
| Vesna Deep Tech Fund | Series A |
| Guinness Ventures | Series A |
| Kadmos Capital | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2025
$9M round closed
- Feb 19, 2024
$4M round led by Kadmos Capital and LAUNCHub Ventures
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withAug 20, 2026
GlycanAge Ltd. and ExoEarth corp. form a strategic collaboration in Japan on Aug 20th '26 to expand glycan-based biological age testing and pursue joint research into aging biology under a Memorandum of Understanding.
For institutional investors. Book with your work email.
GlycanAge Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GlycanAge's valuation, stock price, and market status.
Is GlycanAge a public or private company?
GlycanAge is a private company.
What is the current stock price of GlycanAge?
GlycanAge is a private company, so its shares have no public market price. Caplight tracks GlycanAge's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GlycanAge worth (valuation)?
Valuation information for GlycanAge is not publicly available.
Can I buy GlycanAge stock?
GlycanAge shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GlycanAge's last funding round?
GlycanAge's most recent funding round was Series A on December 18, 2025.
Who are the main investors in GlycanAge?
Key investors in GlycanAge include Kadmos Capital, LAUNCHub Ventures, Fifth Quarter Ventures.
Will GlycanAge IPO soon?
No public IPO plans have been announced for GlycanAge.
How can I track GlycanAge secondary market activity?
Caplight tracks bids, offers, and trades in GlycanAge's shares on secondary markets.